Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $2.893B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MIRATI THERAPEUTICS INC | 3,862,500 | $398M | 13.8% | $18.96 | — | Common | 60468T105 |
| — | IMMUNOMEDICS INC | 21,000,000 | $291M | 10.1% | $9.03 | — | Common | 452907108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 10,752,585 | $264M | 9.1% | $10.01 | +50.4% | Common | 462260100 |
| ASND | ASCENDIS PHARMA | 1,970,000 | $227M | 7.8% | $42.74 | — | Sponsored ADR | 04351P101 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,400,000 | $213M | 7.4% | $105.12 | +15.6% | Common | 803607100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,115,000 | $181M | 6.3% | $85.80 | -0.3% | Common | 09061G101 |
| — | AMARIN CORP PLC | 7,500,000 | $145M | 5.0% | $17.12 | — | Sponsored ADR | 023111206 |
| FOLD | AMICUS THERAPEUTICS INC | 10,000,000 | $125M | 4.3% | $10.41 | +21.9% | Common | 03152W109 |
| ARGX | ARGENX SE | 840,000 | $119M | 4.1% | $50.15 | — | Sponsored ADR | 04016X101 |
| — | ZOGENIX INC | 2,025,000 | $96.75M | 3.3% | $37.94 | — | Common | 98978L204 |
| — | HORIZON THERAPEUTICS PLC | 4,000,000 | $96.24M | 3.3% | $24.06 | — | Common | G46188101 |
| — | ARRAY BIOPHARMA INC | 2,000,000 | $92.66M | 3.2% | $24.38 | — | Common | 04269X105 |
| — | ATHENEX INC | 4,605,000 | $91.18M | 3.2% | $19.80 | — | Common | 04685N103 |
| — | TRICIDA INC | 2,200,000 | $86.81M | 3.0% | $32.26 | — | Common | 89610F101 |
| — | MYOKARDIA INC | 1,375,000 | $68.94M | 2.4% | $51.49 | — | Common | 62857M105 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 950,000 | $49.97M | 1.7% | $44.49 | — | Common | 37890U108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 3,500,000 | $41.62M | 1.4% | $11.89 | — | Common | 00773U108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 360,000 | $37.73M | 1.3% | $153.98 | -30.4% | Common | 558868105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,325,000 | $35.42M | 1.2% | $23.35 | +9.4% | Common | 004225108 |
| — | BIODELIVERY SCIENCES INTL | 7,424,867 | $34.53M | 1.2% | $3.56 | — | Common | 09060J106 |
| — | MEDICINES CO | 925,000 | $33.73M | 1.2% | $27.95 | — | Common | 584688105 |
| PTCT | PTC THERAPEUTICS INC | 684,000 | $30.78M | 1.1% | $39.49 | 0.0% | Common | 69366J200 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,128,594 | $30.3M | 1.0% | $26.57 | +4.9% | Common | 019770106 |
| XENE | XENON PHARMACEUTICALS INC | 2,400,000 | $23.66M | 0.8% | $8.86 | +8.0% | Common | 98420N105 |
| — | CYMABAY THERAPEUTICS INC | 2,700,000 | $19.33M | 0.7% | $8.80 | — | Common | 23257D103 |
| PCRX | PACIRA BIOSCIENCES INC | 400,000 | $17.4M | 0.6% | $38.49 | +10.3% | Common | 695127100 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 200,000 | $9.66M | 0.3% | $44.30 | 0.0% | Common | 00650F109 |
| KOD | KODIAK SCIENCES INC | 577,021 | $6.751M | 0.2% | $8.85 | +0.5% | Common | 50015M109 |
| — | ALIMERA SCIENCES INC | 6,240,000 | $5.554M | 0.2% | $1.43 | — | Common | 016259103 |
| SRPT | SAREPTA THERAPEUTICS INC | 250,000 | $5.463M | 0.2% | $105.12 | +15.6% | Call | 803607100 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,105,999 | $4.424M | 0.2% | $11.09 | -61.8% | Common | 31447P100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 285,714 | $4.286M | 0.1% | $17.45 | 0.0% | Common | 77313F106 |
| — | INTEC PHARMA LTD | 820,000 | $3.559M | 0.1% | $8.29 | — | Common | M53644106 |
| — | TELIGENT INC | 5,231,206 | $3.296M | 0.1% | $7.35 | — | Common | 87960W104 |
| IWM | iShares Russell 2000 | 250,000 | $110K | 0.0% | — | — | Put | 464287655 |